Arecor Therapeutics PLC (LSE:AREC)
£ 0.765 0 (0%) Market Cap: 28.88 Mil Enterprise Value: 26.62 Mil PE Ratio: 0 PB Ratio: 4.58 GF Score: 63/100

Arecor Therapeutics PLC to Present the Year End Results Transcript

May 05, 2022 / 09:00AM GMT
Release Date Price: £4.2
Operator

Good morning, ladies and gentlemen, and welcome to the Arecor Therapeutics plc year-end results investor presentation. (Operator Instructions) Before we begin, I would like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful.

And I'd now like to hand you over to CEO, Sarah Howell. Good morning to you.

Sarah Jennifer Howell
Arecor Therapeutics plc - CEO & Director

Good morning. Thank you, Jake. So good morning, everybody. Thank you for taking the time to join us today. It's a pleasure to be here. So my name is Dr. Sarah Howell, I'm the CEO of Arecor, and I'm joined today by Susan Lowther, our CFO. And today we really will give you an introduction to Arecor, our technology and the proprietary products that we're developing and also kind of some of the highlights from our year ending 31st of December 2021.

So to draw your attention to our customary legal notice. So by wave introduction at Arecor, we -- our purpose here is to transform patient care by enhancing existing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot